{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:04:44Z","timestamp":1793855084972,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Graduate Research and Innovation Project of the Chongqing Education Committee","award":["CYS23351"],"award-info":[{"award-number":["CYS23351"]}]},{"name":"Research Project of Fuling District of Chongqing City","award":["No. FLKJ, 2024AAN3058"],"award-info":[{"award-number":["No. FLKJ, 2024AAN3058"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072353"],"award-info":[{"award-number":["82072353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"DOI":"10.1186\/s40170-025-00401-6","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T14:11:17Z","timestamp":1750255877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia"],"prefix":"10.1186","volume":"13","author":[{"given":"Jiayuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"401_CR1","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.22233","volume":"107","author":"B Deschler","year":"2006","unstructured":"Deschler B, L\u00fcbbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:2099\u2013107.","journal-title":"Cancer"},{"key":"401_CR2","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401:2073\u201386.","journal-title":"Lancet"},{"key":"401_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1182\/blood-2010-08-299990","volume":"117","author":"B Falini","year":"2011","unstructured":"Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, Haferlach T. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood. 2011;117:1109\u201320.","journal-title":"Blood"},{"key":"401_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","volume":"136","author":"B Falini","year":"2020","unstructured":"Falini B, Brunetti L, Sportoletti P, Martelli MP. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020;136:1707\u201321.","journal-title":"Blood"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, et al. Current status and future perspectives in targeted therapy of NPM1-mutated AML. Leukemia. 2022;36:2351\u201367.","journal-title":"Leukemia"},{"key":"401_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1200\/JCO.2009.25.1496","volume":"28","author":"H Becker","year":"2010","unstructured":"Becker H, Marcucci G, Maharry K, Radmacher MD, Mr\u00f3zek K, Margeson D, et al. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de Novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and leukemia group B study. J Clin Oncol. 2010;28:596\u2013604.","journal-title":"J Clin Oncol"},{"key":"401_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1600-0609.2007.01019.x","volume":"80","author":"S Scholl","year":"2008","unstructured":"Scholl S, Theuer C, Scheble V, Kunert C, Heller A, M\u00fcgge LO. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 year with acute myeloid leukaemia. Eur J Haematol. 2008;80:208\u201315.","journal-title":"Eur J Haematol"},{"key":"401_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"401_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21:363\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1535-7163.MCT-19-0103","volume":"19","author":"X Tang","year":"2020","unstructured":"Tang X, Fu X, Liu Y, Yu D, Cai SJ, Yang C. Blockade of glutathione metabolism in IDH1-Mutated glioma. Mol Cancer Ther. 2020;19:221\u201330.","journal-title":"Mol Cancer Ther"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"9964","DOI":"10.1073\/pnas.1913633117","volume":"117","author":"D Yu","year":"2020","unstructured":"Yu D, Liu Y, Zhou Y, Ruiz-Rodado V, Larion M, Xu G, Yang C. Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. Proc Natl Acad Sci USA. 2020;117:9964\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"401_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/jnci\/djy230","volume":"111","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu Y, Celiku O, Li A, Wu Q, Zhou Y, Yang C. Targeting IDH1-Mutated malignancies with NRF2 Blockade. J Natl Cancer Inst. 2019;111:1033\u201341.","journal-title":"J Natl Cancer Inst"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/antiox11040717","volume":"11","author":"S Kannan","year":"2022","unstructured":"Kannan S, Irwin ME, Herbrich SM, Cheng T, Patterson LL, Aitken MJL, et al. Targeting the NRF2\/HO-1 antioxidant pathway in FLT3-ITD-Positive AML enhances therapy efficacy. Antioxid (Basel). 2022;11:717.","journal-title":"Antioxid (Basel)"},{"key":"401_CR14","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1158\/2159-8290.CD-21-0177","volume":"11","author":"HC Wu","year":"2021","unstructured":"Wu HC, R\u00e9rolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, et al. Actinomycin D targets NPM1c-Primed mitochondria to restore PML-Driven senescence in AML therapy. Cancer Discov. 2021;11:3198\u2013213.","journal-title":"Cancer Discov"},{"key":"401_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.redox.2014.02.006","volume":"2","author":"HS Marinho","year":"2014","unstructured":"Marinho HS, Real C, Cyrne L, Soares H, Antunes F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2014;2:535\u201362.","journal-title":"Redox Biol"},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in Cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"401_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39:199\u2013218.","journal-title":"Trends Biochem Sci"},{"key":"401_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M de la Rojo","year":"2018","unstructured":"de la Rojo M, Chapman E, Zhang DD. NRF2 and the hallmarks of Cancer. Cancer Cell. 2018;34:21\u201343.","journal-title":"Cancer Cell"},{"key":"401_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106\u20139.","journal-title":"Nature"},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","volume":"28","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Muramatsu A, Saito R, Iso T, Shibata T. Kuwata Ket al. Molecular mechanism of cellular oxidative stress sensing by Keap1. Cell Rep. 2019;28:746\u201358.","journal-title":"Cell Rep"},{"key":"401_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molcel.2023.11.001","volume":"84","author":"F Hecht","year":"2024","unstructured":"Hecht F, Zocchi M, Alimohammadi F, Harris IS. Regulation of antioxidants in cancer. Mol Cell. 2024;84:23\u201333.","journal-title":"Mol Cell"},{"key":"401_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2022.03.029","volume":"184","author":"C Wolowczyk","year":"2022","unstructured":"Wolowczyk C, Neckmann U, Aure MR, Hall M, Johannessen B, Zhao S, et al. NRF2 drives an oxidative stress response predictive of breast cancer. Free Radic Biol Med. 2022;184:170\u201384.","journal-title":"Free Radic Biol Med"},{"key":"401_CR23","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/s41418-019-0303-z","volume":"26","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhang ZY, Du H, Li SZ, Tu R, Jia YF, et al. DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer. Cell Death Differ. 2019;26:2300\u201313.","journal-title":"Cell Death Differ"},{"key":"401_CR24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-17-3155","volume":"78","author":"YX Lu","year":"2018","unstructured":"Lu YX, Ju HQ, Liu ZX, Chen DL, Wang Y, Zhao Q, et al. ME1 regulates NADPH homeostasis to promote gastric Cancer growth and metastasis. Cancer Res. 2018;78:1972\u201385.","journal-title":"Cancer Res"},{"key":"401_CR25","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-Deficient NSCLC tumors. ACS Chem Biol. 2016;11:3214\u201325.","journal-title":"ACS Chem Biol"},{"key":"401_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","volume":"1","author":"E Kansanen","year":"2013","unstructured":"Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in Cancer. Redox Biol. 2013;1:45\u20139.","journal-title":"Redox Biol"},{"key":"401_CR27","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.3390\/ijms25137011","volume":"25","author":"EJ Jeong","year":"2024","unstructured":"Jeong EJ, Choi JJ, Lee SY, Kim YS. The effects of ML385 on head and neck squamous cell carcinoma: implications for NRF2 Inhibition as a therapeutic strategy. Int J Mol Sci. 2024;25:7011.","journal-title":"Int J Mol Sci"},{"key":"401_CR28","doi-asserted-by":"crossref","unstructured":"Cunningham A, Oudejans LL, Geugien M, Pereira-Martins DA, Wierenga ATJ, Erdem A et al. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia.blood adv. 2024;8: 56\u201369.","DOI":"10.1182\/bloodadvances.2023010786"},{"key":"401_CR29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/bloodadvances.2019001267","volume":"4","author":"CA Lachowiez","year":"2020","unstructured":"Lachowiez CA, Loghavi S, Kadia TM, Daver N, Borthakur G, Pemmaraju N, et al. Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens. Blood Adv. 2020;4:1311\u201320.","journal-title":"Blood Adv"},{"key":"401_CR30","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1182\/bloodadvances.2020003734","volume":"5","author":"M Stahl","year":"2021","unstructured":"Stahl M, Menghrajani K, Derkach A, Chan A, Xiao W, Glass J, et al. Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed\/refractory AML. Blood Adv. 2021;5:1552\u201364.","journal-title":"Blood Adv"},{"key":"401_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41419-022-05357-9","volume":"13","author":"J Ren","year":"2022","unstructured":"Ren J, Tao Y, Peng M, Xiao Q, Jing Y, Huang J, et al. Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8\u2009+\u2009T cell immune function in acute myeloid leukemia. Cell Death Dis. 2022;13:915.","journal-title":"Cell Death Dis"},{"key":"401_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-024-03100-0","volume":"43","author":"J Ren","year":"2024","unstructured":"Ren J, Huang J, Yang Z, Sun M, Yang J, Lin C, et al. Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia. J Exp Clin Cancer Res. 2024;43:176.","journal-title":"J Exp Clin Cancer Res"},{"key":"401_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.31761","volume":"74","author":"D Lee","year":"2021","unstructured":"Lee D, Zhang MS, Tsang FH, Bao MH, Xu IM, Lai RK, et al. Adaptive and constitutive activations of malic enzymes confer liver Cancer multilayered protection against reactive oxygen species. Hepatology. 2021;74:776\u201396.","journal-title":"Hepatology"},{"key":"401_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. GIMEMA acute leukemia working party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352:254\u201366.","journal-title":"N Engl J Med"},{"key":"401_CR35","doi-asserted-by":"publisher","first-page":"817584","DOI":"10.3389\/fonc.2022.817584","volume":"12","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Lei L, Ren J, Peng M, Jing Y, Jiang X, et al. Mutant NPM1-Regulated FTO-Mediated m6A demethylation promotes leukemic cell survival via PDGFRB\/ERK signaling Axis. Front Oncol. 2022;12:817584.","journal-title":"Front Oncol"},{"key":"401_CR36","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/ijms24021624","volume":"24","author":"J Huang","year":"2023","unstructured":"Huang J, Sun M, Tao Y, Ren J, Peng M, Jing Y, et al. Cytoplasmic expression of TP53INP2 modulated by demethylase FTO and mutant NPM1 promotes autophagy in leukemia cells. Int J Mol Sci. 2023;24:1624.","journal-title":"Int J Mol Sci"},{"key":"401_CR37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931\u201347.","journal-title":"Nat Rev Drug Discov"},{"key":"401_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41467-022-28737-3","volume":"13","author":"A Erdem","year":"2022","unstructured":"Erdem A, Marin S, Pereira-Martins DA, Cort\u00e9s R, Cunningham A, Pruis MG, et al. The glycolytic gatekeeper PDK1 defines different metabolic States between genetically distinct subtypes of human acute myeloid leukemia. Nat Commun. 2022;13:1105.","journal-title":"Nat Commun"},{"key":"401_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9\u201317.","journal-title":"Nat Chem Biol"},{"key":"401_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","volume":"30","author":"IS Harris","year":"2020","unstructured":"Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in Cancer. Trends Cell Biol. 2020;30:440\u201351.","journal-title":"Trends Cell Biol"},{"key":"401_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.redox.2017.04.013","volume":"12","author":"L Milkovic","year":"2017","unstructured":"Milkovic L, Zarkovic N, Saso L. Controversy about Pharmacological modulation of Nrf2 for cancer therapy. Redox Biol. 2017;12:727\u201332.","journal-title":"Redox Biol"},{"key":"401_CR42","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1182\/blood-2012-04-422121","volume":"120","author":"SA Rushworth","year":"2012","unstructured":"Rushworth SA, Zaitseva L, Murray MY, Shah NM, Bowles KM, MacEwan DJ. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance. Blood. 2012;120:5188\u201398.","journal-title":"Blood"},{"key":"401_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu X, Zhong S, Qiu K, Chen X, Wu W, Zheng J, et al. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol. 2023;12:47.","journal-title":"Exp Hematol Oncol"},{"key":"401_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2024","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BMT. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. 2024;25:46\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"401_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2018.02.004","volume":"113","author":"X Guo","year":"2018","unstructured":"Guo X, Jiang Q, Tuccitto A, Chan D, Alqawlaq S, Won GJ, Sivak JM. The AMPK-PGC-1\u03b1 signaling axis regulates the astrocyte glutathione system to protect against oxidative and metabolic injury. Neurobiol Dis. 2018;113:59\u201369.","journal-title":"Neurobiol Dis"},{"key":"401_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/leu.2017.30","volume":"31","author":"EM Heath","year":"2017","unstructured":"Heath EM, Chan SM, Minden MD, Murphy T, Shlush LI, Schimmer AD. Biological and clinical consequences of NPM1 mutations in AML. Leukemia. 2017;31:798\u2013807.","journal-title":"Leukemia"},{"key":"401_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2024.01.013","volume":"213","author":"A Sang","year":"2024","unstructured":"Sang A, Zhang J, Zhang M, Xu D, Xuan R, Wang S, et al. METTL4 mediated-N6-methyladenosine promotes acute lung injury by activating ferroptosis in alveolar epithelial cells. Free Radic Biol Med. 2024;213:90\u2013101.","journal-title":"Free Radic Biol Med"},{"key":"401_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/ars.2012.5082","volume":"20","author":"SR Kulkarni","year":"2014","unstructured":"Kulkarni SR, Donepudi AC, Xu J, Wei W, Cheng QC, Driscoll MV, et al. Fasting induces nuclear factor E2-related factor 2 and ATP-binding cassette transporters via protein kinase A and Sirtuin-1 in mouse and human. Antioxid Redox Signal. 2014;20:15\u201330.","journal-title":"Antioxid Redox Signal"},{"key":"401_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-023-02684-3","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Zhang Q, Zhao Z, Qiu Y, Zhou Y, Wu Z, et al. Epigenetically silenced LncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1. J Exp Clin Cancer Res. 2023;42:127.","journal-title":"J Exp Clin Cancer Res"},{"key":"401_CR50","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nmeth.4306","volume":"14","author":"R Tao","year":"2017","unstructured":"Tao R, Zhao Y, Chu H, Wang A, Zhu J, Chen X, et al. Genetically encoded fluorescent sensors reveal dynamic regulation of NADPH metabolism. Nat Methods. 2017;14:720\u20138.","journal-title":"Nat Methods"},{"key":"401_CR51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature13236","volume":"510","author":"J Fan","year":"2014","unstructured":"Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014;510:298\u2013302.","journal-title":"Nature"},{"key":"401_CR52","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, Pasanisi J, Ling F, Dal Bello R, Penneroux J, Su A, et al. Cystine uptake Inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36:1585\u201395.","journal-title":"Leukemia"},{"key":"401_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","volume":"18","author":"H D\u00f6hner","year":"2021","unstructured":"D\u00f6hner H, Wei AH, L\u00f6wenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18:577\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"401_CR54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12964-022-00978-1","volume":"20","author":"X Chu","year":"2022","unstructured":"Chu X, Zhong L, Dan W, Wang X, Zhang Z, Liu Z, et al. DNMT3A R882H mutation drives Daunorubicin resistance in acute myeloid leukemia via regulating NRF2\/NQO1 pathway. Cell Commun Signal. 2022;20:168.","journal-title":"Cell Commun Signal"},{"key":"401_CR55","doi-asserted-by":"publisher","first-page":"102798","DOI":"10.1016\/j.jbc.2022.102798","volume":"299","author":"Q Shang","year":"2023","unstructured":"Shang Q, Pan C, Zhang X, Yang T, Hu T, Zheng L, et al. Nuclear factor Nrf2 promotes glycosidase OGG1 expression by activating the AKT pathway to enhance leukemia cell resistance to cytarabine. J Biol Chem. 2023;299:102798.","journal-title":"J Biol Chem"},{"key":"401_CR56","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.biopha.2021.111652","volume":"142","author":"C Cheng","year":"2021","unstructured":"Cheng C, Yuan F, Chen XP, Zhang W, Zhao XL, Jiang ZP, et al. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C. Biomed Pharmacother. 2021;142:111652.","journal-title":"Biomed Pharmacother"},{"key":"401_CR57","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.3390\/ijms251910257","volume":"25","author":"M Juszczak","year":"2024","unstructured":"Juszczak M, Tokarz P, Wo\u017aniak K. Potential of NRF2 Inhibitors-Retinoic acid, K67, and ML-385-In overcoming doxorubicin resistance in promyelocytic leukemia cells. Int J Mol Sci. 2024;25:10257.","journal-title":"Int J Mol Sci"},{"key":"401_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, et al. Venetoclax combined with decitabine or Azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019;133:7\u201317.","journal-title":"Blood"},{"key":"401_CR59","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, et al. Venetoclax with Azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24:1859\u201366.","journal-title":"Nat Med"},{"key":"401_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Wang Y, Tan J, Li Y, Yang P, Liu X, et al. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov. 2024;10:35.","journal-title":"Cell Death Discov"}],"container-title":["Cancer &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-025-00401-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:02:32Z","timestamp":1750258952000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/s40170-025-00401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1186\/s40170-025-00401-6","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was given by the Medical Ethics Committee of Chongqing Medical University. All animal procedures to be employed in the project was approved by Institutional Animal Care and Use of Chongqing Medical University (Approval number: IACUC-CQMU-2025-0338).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}